Naltrexone
6
2
2
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
16.7%
1 terminated out of 6 trials
66.7%
-19.9% vs benchmark
17%
1 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (6)
Understanding How Opioids Affect the Experiential and Neural Signatures of Social Experiences
IC PaIN Trial: Interstitial Cystitis Pain Improvement With Naltrexone
Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1
Effectiveness of Low-dose Naltrexone in Patients With Different Types of Vulvodynia
RCT for Gambling and Naltrexone, Using Use Eye-tracking Analysis to Predict Treatment Response
Study for Naltrexone on the Abuse Potential of Methylphenidate